Ranibizumab Intraocular and Trabectedin Intravenous
Determining the interaction of Ranibizumab Intraocular and Trabectedin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: trabectedin
Brand name: Yondelis
Synonyms: Trabectedin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Trace Elements
- Ranibizumab Intraocular-Trace Elements 4 Injection
- Ranibizumab Intraocular-Tracleer
- Ranibizumab Intraocular-Tracleer (Bosentan Tablets for Oral Suspension)
- Ranibizumab Intraocular-Tracleer (Bosentan Tablets)
- Ranibizumab Intraocular-Tradjenta
- Trabectedin Intravenous-Ranibizumab ophthalmic
- Trabectedin Intravenous-Ranitidine
- Trabectedin Intravenous-Ranitidine Capsule
- Trabectedin Intravenous-Ranitidine Hydrochloride
- Trabectedin Intravenous-Ranitidine Injection
- Trabectedin Intravenous-Ranitidine Suspension